Skip to main content
SpringerLink
Log in

Tuberin, p27 and mTOR in different cells

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

Mutations in the genes TSC1 or TSC2 cause the autosomal dominantly inherited tumor suppressor syndrome tuberous sclerosis, which is characterized by the development of tumors, named hamartomas, in different organs. The TSC gene products, hamartin and tuberin, form a complex, of which tuberin is assumed to be the functional component. Both, hamartin and tuberin have been implicated in the control of the cell cycle by activating the cyclin-dependent kinase inhibitor p27 and in cell size regulation by inhibiting the mammalian target of rapamycin (mTOR) a regulator of the p70 ribosomal protein S6 kinase (p70S6K) and its target the ribosomal protein S6. The tuberin/hamartin complex was shown to protect p27 from protein degradation. Within the mTOR signaling pathway tuberin harbors GTPase activating (GAP) potential toward Rheb, which is a potent regulator of mTOR. In this study, we have analyzed the protein levels of tuberin, p27, cyclin D1, mTOR and phospho mTOR Ser2448 (activated mTOR), S6 and phospho S6 Ser240/244 (activated S6) and as controls α-tubulin and topoisomerase IIβ, in ten different cells, including primary normal cells, immortalized and transformed cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Astrinidis A, Henske EP (2005) Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene 24:7475–7481

    Article  PubMed  CAS  Google Scholar 

  • Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM (2004) p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862–876

    Article  PubMed  CAS  Google Scholar 

  • Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D, Clurman BE, Dyer MA, Roberts JM (2007) Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 21:1731–1746

    Article  PubMed  CAS  Google Scholar 

  • Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12:487–502

    Article  PubMed  CAS  Google Scholar 

  • Blain SW, Scher HI, Cordon-Cardo C, Koff A (2003) p27 as a target for cancer therapeutics. Cancer Cell 3:111–115

    Article  PubMed  CAS  Google Scholar 

  • Corradetti MN, Guan K-L (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25:6347–6360

    Article  PubMed  CAS  Google Scholar 

  • Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. New Engl J Med 355:1345–1356

    Article  PubMed  CAS  Google Scholar 

  • Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF (2007) Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res 67:9238–9243

    Article  PubMed  CAS  Google Scholar 

  • Freilinger A, Rosner M, Hengstschläger M (2006a) Tuberin negatively affects BCL-2’s cell survival function. Amino Acids 30:391–396

    Article  PubMed  CAS  Google Scholar 

  • Freilinger A, Rosner M, Krupitza G, Nishino M, Lubec G, Korsmeyer, Hengstschläger M (2006b) Tuberin activates the proapoptotic molecule BAD. Oncogene 25:6467–6479

    Article  PubMed  CAS  Google Scholar 

  • Freilinger A, Rosner M, Hanneder M, Hengstschläger M (2008) Ras mediates cell survival by regulating tuberin. Oncogene. doi:10.1038/sj.onc.1210844

  • Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22

    Article  PubMed  CAS  Google Scholar 

  • Henry KW, Yuan X, Koszewski NJ, Onda H, Kwiatkowski DJ, Noonan DJ (1998) Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 273:20535–20539

    Article  PubMed  CAS  Google Scholar 

  • Inoki K, Zhu T, Guan K-L (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115:577–590

    Article  PubMed  CAS  Google Scholar 

  • Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129:1261–1274

    Article  PubMed  CAS  Google Scholar 

  • Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschläger M (2000) The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet 9:1721–1727

    Article  PubMed  CAS  Google Scholar 

  • Musgrove EA (2006) Cyclins: roles in mitogenic signaling and oncogenic transformation. Growth Factors 24:13–19

    Article  PubMed  CAS  Google Scholar 

  • Nho RS, Sheaff RJ (2003) p27kip1 contributes to cancer. Prog Cell Cycle Res 5:249–259

    PubMed  Google Scholar 

  • Pan D, Dong J, Zhang Y, Gao X (2004) Tuberous sclerosis complex: from Drosophila to human disease. Trends Cell Biol 14:78–85

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Hengstschläger M (2004) Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2. J Biol Chem 279:48707–48715

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Hengstschläger M (2007) Cytoplasmic/nuclear localization of tuberin in different cell lines. Amino Acids 33:575–579

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Hofer K, Kubista M, Hengstschläger M (2003) Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 22:4786–4798

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Freilinger A, Hengstschläger M (2004) Proteins interacting with the tuberous sclerosis gene products. Amino Acids 27:119–128

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Freilinger A, Hanneder M, Fujita N, Lubec G, Tsuruo T, Hengstschläger M (2007a) p27 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 16:1541–1556

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Freilinger A, Hengstschläger M (2007b) Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene 26:521–531

    Article  PubMed  CAS  Google Scholar 

  • Rosner M, Hanneder M, Siegel N, Valli A, Hengstschläger M (2008) The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat Res Rev Mutat Res. doi:10.1016/j.mmrev.2008.01.001

  • Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 14:1650–1656

    Article  PubMed  CAS  Google Scholar 

  • Sicinski P, Zacharek S, Kim C (2007) Duality of p27Kip1 function in tumorigenesis. Genes Dev 21:1703–1706

    Article  PubMed  CAS  Google Scholar 

  • Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschläger M (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control. J Biol Chem 272:29301–29308

    Article  PubMed  CAS  Google Scholar 

  • Soucek T, Hölzl G, Bernaschek G, Hengstschläger M (1998a) A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 16:2197–2204

    Article  PubMed  CAS  Google Scholar 

  • Soucek T, Yeung RS, Hengstschläger M (1998b) Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 95:15653–15658

    Article  PubMed  CAS  Google Scholar 

  • The European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315

    Google Scholar 

  • The TSC1 Consortium (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808

    Article  Google Scholar 

  • Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124:471–484

    Article  PubMed  CAS  Google Scholar 

  • Xiao G-H, Shoarinejad F, Jin F, Golemis EA, Yeung RS (1997) The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 272:6097–6100

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Genetics, Obstetrics and Gynecology, Medical University of Vienna, Währinger Gürtel 18–20, 1090, Vienna, Austria

    S. Burgstaller, M. Rosner, C. Lindengrün, M. Hanneder, N. Siegel, A. Valli, C. Fuchs & M. Hengstschläger

Authors
  1. S. Burgstaller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Rosner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Lindengrün
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Hanneder
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Valli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Hengstschläger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Hengstschläger.

Additional information

S. Burgstaller and M. Rosner equally contributed to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burgstaller, S., Rosner, M., Lindengrün, C. et al. Tuberin, p27 and mTOR in different cells. Amino Acids 36, 297–302 (2009). https://doi.org/10.1007/s00726-008-0066-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-008-0066-1

Keywords

Search

Navigation